Literature DB >> 28285409

Pharmacological blockade of small conductance Ca2+-activated K+ channels by ICA reduces arrhythmic load in rats with acute myocardial infarction.

Laura A Hundahl1, Stefan M Sattler2, Lasse Skibsbye3, Jonas G Diness4, Jacob Tfelt-Hansen2, Thomas Jespersen3.   

Abstract

Acute myocardial infarction (AMI) with development of ventricular fibrillation (VF) is a common cause of sudden cardiac death (SCD). At present, no pharmacological treatment has successfully been able to prevent VF in the acute stage of AMI. This study investigates the antiarrhythmic effect of inhibiting small conductance Ca2+-activated K+ (SK) channels using the pore blocker N-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (ICA) in AMI rats. Acute coronary ligation was performed in 26 anesthetized rats, and ECG, monophasic action potentials (MAPs), and ventricular effective refractory period (vERP) were recorded. Rats were randomized into four groups: (i) 3 mg/kg i.v. ICA with AMI (AMI-ICA-group, n = 9), (ii) vehicle with AMI (AMI-vehicle-group, n = 9), (iii) vehicle with sham operation (sham-vehicle-group, n = 8), and (iv) 3 mg/kg i.v. ICA with sham operation (sham-ICA-group, n = 6). At the end of experiments, hearts were stained for the non-perfused area at risk (AAR). AMI resulted in the development of ventricular tachycardia (VT) in all AMI-vehicle and AMI-ICA rats; however, ICA significantly decreased VT duration. VF occurred in 44% of AMI-vehicle rats but not in AMI-ICA rats. Monophasic action potential duration at 80% repolarization (MAPD80) in the ischemic area decreased rapidly in both AMI-vehicle and AMI-ICA rats. However, 5 min after occlusion, MAPD80 returned to baseline in AMI-ICA rats but not in AMI-vehicle rats. The vERP was prolonged in the AMI-ICA group compared to AMI-vehicle after ligation. AAR was similar between the AMI-vehicle group and the AMI-ICA group. In rats with AMI, ICA reduces the burden of arrhythmia.

Entities:  

Keywords:  Acute myocardial infarction; Calcium-activated potassium channels; N-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine; Ventricular arrhythmia

Mesh:

Substances:

Year:  2017        PMID: 28285409     DOI: 10.1007/s00424-017-1962-6

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  56 in total

1.  Mechanism of calcium gating in small-conductance calcium-activated potassium channels.

Authors:  X M Xia; B Fakler; A Rivard; G Wayman; T Johnson-Pais; J E Keen; T Ishii; B Hirschberg; C T Bond; S Lutsenko; J Maylie; J P Adelman
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

2.  Biophysical characterization of inwardly rectifying potassium currents (I(K1) I(K,ACh), I(K,Ca)) using sinus rhythm or atrial fibrillation action potential waveforms.

Authors:  Chuyi Tang; Lasse Skibsbye; Lei Yuan; Bo H Bentzen; Thomas Jespersen
Journal:  Gen Physiol Biophys       Date:  2015-10       Impact factor: 1.512

3.  The small neurotoxin apamin blocks not only small conductance Ca2+ activated K+ channels (SK type) but also the voltage dependent Kv1.3 channel.

Authors:  Patrick Voos; Mehtap Yazar; René Lautenschläger; Oliver Rauh; Anna Moroni; Gerhard Thiel
Journal:  Eur Biophys J       Date:  2017-01-20       Impact factor: 1.733

4.  EuReCa ONE-27 Nations, ONE Europe, ONE Registry: A prospective one month analysis of out-of-hospital cardiac arrest outcomes in 27 countries in Europe.

Authors:  Jan-Thorsten Gräsner; Rolf Lefering; Rudolph W Koster; Siobhán Masterson; Bernd W Böttiger; Johan Herlitz; Jan Wnent; Ingvild B M Tjelmeland; Fernando Rosell Ortiz; Holger Maurer; Michael Baubin; Pierre Mols; Irzal Hadžibegović; Marios Ioannides; Roman Škulec; Mads Wissenberg; Ari Salo; Hervé Hubert; Nikolaos I Nikolaou; Gerda Lóczi; Hildigunnur Svavarsdóttir; Federico Semeraro; Peter J Wright; Carlo Clarens; Ruud Pijls; Grzegorz Cebula; Vitor Gouveia Correia; Diana Cimpoesu; Violetta Raffay; Stefan Trenkler; Andrej Markota; Anneli Strömsöe; Roman Burkart; Gavin D Perkins; Leo L Bossaert
Journal:  Resuscitation       Date:  2016-06-16       Impact factor: 5.262

Review 5.  Frequency of sudden cardiac death and profiles of risk.

Authors:  R J Myerburg; A Interian; R M Mitrani; K M Kessler; A Castellanos
Journal:  Am J Cardiol       Date:  1997-09-11       Impact factor: 2.778

6.  Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators.

Authors: 
Journal:  Lancet       Date:  1997-11-15       Impact factor: 79.321

7.  Apamin induces early afterdepolarizations and torsades de pointes ventricular arrhythmia from failing rabbit ventricles exhibiting secondary rises in intracellular calcium.

Authors:  Po-Cheng Chang; Yu-Cheng Hsieh; Chia-Hsiang Hsueh; James N Weiss; Shien-Fong Lin; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2013-07-05       Impact factor: 6.343

8.  The duration of pacing-induced atrial fibrillation is reduced in vivo by inhibition of small conductance Ca(2+)-activated K(+) channels.

Authors:  Lasse Skibsbye; Jonas Goldin Diness; Ulrik Svane Sørensen; Rie Schultz Hansen; Morten Grunnet
Journal:  J Cardiovasc Pharmacol       Date:  2011-06       Impact factor: 3.105

9.  Synthesis and structure-activity relationship studies of 2-(N-substituted)-aminobenzimidazoles as potent negative gating modulators ofsmall conductance Ca2+-activated K+ channels.

Authors:  Ulrik S Sørensen; Dorte Strøbaek; Palle Christophersen; Charlotte Hougaard; Marianne L Jensen; Elsebet Ø Nielsen; Dan Peters; Lene Teuber
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

10.  Does small-conductance calcium-activated potassium channel contribute to cardiac repolarization?

Authors:  Norbert Nagy; Viktória Szuts; Zoltán Horváth; György Seprényi; Attila S Farkas; Károly Acsai; János Prorok; Miklós Bitay; Attila Kun; János Pataricza; Julius Gy Papp; Péter P Nánási; András Varró; András Tóth
Journal:  J Mol Cell Cardiol       Date:  2009-07-24       Impact factor: 5.000

View more
  6 in total

1.  The Natural Flavone Acacetin Blocks Small Conductance Ca2+-Activated K+ Channels Stably Expressed in HEK 293 Cells.

Authors:  Kui-Hao Chen; Hui Liu; Hai-Ying Sun; Man-Wen Jin; Guo-Sheng Xiao; Yan Wang; Gui-Rong Li
Journal:  Front Pharmacol       Date:  2017-10-10       Impact factor: 5.810

2.  Ca2+/Calmodulin-Dependent Protein Kinase II (CaMKII) Increases Small-Conductance Ca2+-Activated K+ Current in Patients with Chronic Atrial Fibrillation.

Authors:  Xuehui Fan; Yiyan Yu; Huan Lan; Xianhong Ou; Lijie Yang; Tao Li; Jiming Cao; Xiaorong Zeng; Miaoling Li
Journal:  Med Sci Monit       Date:  2018-05-08

3.  Inhibition of KCa2 and Kv11.1 Channels in Pigs With Left Ventricular Dysfunction.

Authors:  Carlotta Citerni; Jeppe Kirchhoff; Lisbeth Høier Olsen; Stefan Michael Sattler; Morten Grunnet; Nils Edvardsson; Bo Hjorth Bentzen; Jonas Goldin Diness
Journal:  Front Pharmacol       Date:  2020-05-06       Impact factor: 5.810

4.  Inhibition of KCa2 Channels Decreased the Risk of Ventricular Arrhythmia in the Guinea Pig Heart During Induced Hypokalemia.

Authors:  Jonas Goldin Diness; Lea Abildgaard; Sofia Hammami Bomholtz; Mark Alexander Skarsfeldt; Nils Edvardsson; Ulrik S Sørensen; Morten Grunnet; Bo Hjorth Bentzen
Journal:  Front Pharmacol       Date:  2020-05-20       Impact factor: 5.810

5.  Impact of arrhythmogenic calmodulin variants on small conductance Ca2+ -activated K+ (SK3) channels.

Authors:  Arnela Saljic; Kalai Mangai Muthukumarasamy; Jonas Marstrand la Cour; Kim Boddum; Morten Grunnet; Martin Werner Berchtold; Thomas Jespersen
Journal:  Physiol Rep       Date:  2019-10

6.  First Clinical Study with AP30663 - a KCa 2 Channel Inhibitor in Development for Conversion of Atrial Fibrillation.

Authors:  Pim Gal; Erica S Klaassen; Kirsten R Bergmann; Mahdi Saghari; Jacobus Burggraaf; Michiel J B Kemme; Christina Sylvest; Ulrik Sørensen; Bo H Bentzen; Morten Grunnet; Jonas G Diness; Nils Edvardsson
Journal:  Clin Transl Sci       Date:  2020-07-29       Impact factor: 4.438

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.